Cited by 90Smoking Behavior and CessationPharmacogenetics and Drug MetabolismPrenatal Substance Exposure Effects

Changes in the rate of nicotine metabolism across pregnancy: a longitudinal study

Open access
Bowker, Katharine, Lewis, Sarah, Coleman, Tim, Cooper, Sue·2015·Addiction

Abstract

Aims: Increased nicotine metabolism during pregnancy could explain why nicotine replacement therapy (NRT) appears to be less effective on smoking cessation in pregnancy than in non‐pregnant smokers, but little is known about nicotine metabolism across pregnancy. This study was conducted to determine when changes in nicotine metabolism occur during pregnancy and to describe the magnitude of these changes. Design: Longitudinal cohort study of pregnant smokers' nicotine metabolite ratio (NMR). Setting and Participants: 101 pregnant smokers recruited from hospital antenatal clinics in Nottingham, UK were asked to provide saliva samples at 8–14 weeks (n = 98), 18–22 weeks (n = 65), 32–36 weeks gestation (n = 47), 4 weeks postpartum (n = 44) and 12 weeks postpartum (n = 47). Measurements: Nicotine metabolite ratio (NMR) was measured using the ratio of cotinine to its primary metabolite trans‐3'‐hydroxycotinine. Multi‐level modelling was used to detect any overall difference in NMR between time points. The 12 week postpartum NMR was compared with the NMRs collected antenatally and 4 weeks postpartum. Findings: NMR changed over time (p = 0.0006). Compared with NMR at 12 weeks postpartum, NMR was significantly higher at 18–22 weeks (26% higher, 95% CI 12% to 38%) and 32–36 weeks (23% higher, 95% CI 9% to 35%). There was no significant difference between the 8‐14 weeks gestation or 4 weeks postpartum NMR and 12 weeks postpartum. Conclusions: Nicotine metabolism appears to be faster during pregnancy; this faster metabolism is apparent from 18 to 22 weeks of pregnancy and appears to fall by 4 weeks after childbirth.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/add.13029

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 20

  1. [3]Coleman T., Chamberlain C., Davey M. A., Cooper S. E., Leornardi‐Bee J. Pharmacological interventions for promoting smoking cessation during pregnancy. Cochrane Database Syst Rev 2012; 9: CD010078. 22972148
  2. [4]Dempsey D., Jacob P., Benowitz N. L. Accelerated metabolism of nicotine and cotinine in pregnant smokers. J Pharmacol Exp Ther 2002; 301: 594– 8. doi: 10.1124/jpet.301.2.594. 11961061 · DOI · Paper page
  3. [5]Blanchette P., Klein J., Christodouleas J., Kramer M., Koren G. Nicotine metabolism in pregnant smokers measured by segmental hair analysis. Clin Pharmacol Ther 2004; 75: P38.
  4. [6]Koren G., Blanchette P., Lubetzky A., Kramer M. Hair nicotine:cotinine metabolic ratio in pregnant women: a new method to study metabolism in late pregnancy. Ther Drug Monit 2008; 30: 246– 8. 18367989
  5. [7]Brajenovic N., Karaconji I. B., Mikolic A., Stasenko S., Piasek M. Tobacco smoke and pregnancy: segmental analysis of nicotine in maternal hair. Arch Environ Occup Health 2013; 68: 117– 22. 23428062
  6. [8]Hukkanen J., Jacob P. III, Benowitz N. L. Effect of grapefruit juice on cytochrome P450 2A6 and nicotine renal clearance. Clin Pharmacol Ther 2006; 80: 522– 30. 17112808
  7. [9]Fagerstrom K. Determinants of tobacco use and renaming the FTND to the Fagerstrom Test for Cigarette Dependence. Nicotine Tob Res 2012; 14: 75– 8. 22025545
  8. [10]Benowitz N. L. Biomarkers of environmental tobacco smoke exposure. Environ Health Perspect 1999; 107: 349– 55. 10350520 PMC1566286
  9. [11]Bernert J. T., Jacob P. III, Holiday D. B., Benowitz N. L., Sosnoff C. S., Doig M. V. et al. Interlaboratory comparability of serum cotinine measurements at smoker and nonsmoker concentration levels: a round‐robin study. Nicotine Tob Res 2009; 11: 1458– 66. 19933777 PMC3167685
  10. [12]West O., Hajek P., McRobbie H. Systematic review of the relationship between the 3‐hydroxycotinine/cotinine ratio and cigarette dependence. Psychopharmacology (Berl) 2011; 218: 313– 22. 21597990
  11. [13]Levi M., Dempsey D. A., Benowitz N. L., Sheiner L. B. Prediction methods for nicotine clearance using cotinine and 3‐hydroxy‐cotinine spot saliva samples II. Model application. J Pharmacokinet Pharmacodyn 2007; 34: 23– 34. 17206525
  12. [14]Dempsey D., Tutka P., Jacob P. III, Allen F., Schoedel K., Tyndale R. F. et al. Nicotine metabolite ratio as an index of cytochrome P450 2A6 metabolic activity. Clin Pharmacol Ther 2004; 76: 64– 72. 15229465
  13. [15]Benowitz N. L., Hukkanen J., Jacob P. III. Nicotine chemistry, metabolism, kinetics and biomarkers. Handbk Exp Pharmacol 2009; 192: 29– 60. PMC2953858 19184645
  14. [16]Kim I., Wtsadik A., Choo R. E., Jones H. E., Huestis M. A. Usefulness of salivary trans‐3'‐hydroxycotinine concentration and trans‐3'‐hydroxycotinine/cotinine ratio as biomarkers of cigarette smoke in pregnant women. J Anal Toxicol 2005; 29: 689– 95. 16419402
  15. [17]Bland J. M., Altman D. G. Multiple significance tests: the Bonferroni method. BMJ 1995; 310: 170. 7833759 PMC2548561
  16. [18]Berlin I., Gasior M. J., Moolchan E. T. Sex‐based and hormonal contraception effects on the metabolism of nicotine among adolescent tobacco‐dependent smokers. Nicotine Tob Res 2007; 9: 493– 8. 17454704
  17. [19]Benowitz N. L., Lessov‐Schlaggar C. N., Swan G. E., Jacob P. III. Female sex and oral contraceptive use accelerate nicotine metabolism. Clin Pharmacol Ther 2006; 79: 480– 8. 16678549
  18. [20]Dawes M., Chowienczyk P. J. Drugs in pregnancy. Pharmacokinetics in pregnancy. Best Pract Res Clin Obstet Gynaecol 2001; 15: 819– 26. 11800526
  19. [21]Anderson G. D. Pregnancy‐induced changes in pharmacokinetics—a mechanistic‐based approach. Clin Pharmacokinet 2005; 44: 989– 1008. 16176115
  20. [22]Brose L. S., McEwen A., West R. Association between nicotine replacement therapy use in pregnancy and smoking cessation. Drug Alcohol Depend 2013; 132: 660– 64. 23680076

Cited by

Sorted by citations

Authors
Bowker, K., Lewis, S., Coleman, T., & Cooper, S.
Affiliations
University of Nottingham (GB)
Corresponding author
Bowker, Katharine
Venue
Addiction
Publisher
Wiley
Published
2015-08-03
Volume
110
Issue
11
Pages
1827-1832
ISSN
  • 0965-2140 (ISSN-L)
  • 1360-0443
OpenAlex
W1571351516
Cited by
90
References
2
Citations by year
2026: 2 · 2025: 9 · 2024: 8 · 2023: 7 · 2022: 11 · 2021: 20 · 2020: 10 · 2019: 7 · 2018: 7 · 2017: 6 · 2016: 3
FWCI
3.89
Type
journal article
Language
en
Open access
Locations
  • Addiction (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Repository@Nottingham (University of Nottingham) (submittedVersion, cc-by-nc)
  • Nottingham ePrints (University of Nottingham) (submittedVersion, cc-by-nc)
Funders
  • National Institute for Health Research
  • University of Nottingham School of Medicine
Topics
  • Health Sciences › Medicine › Physiology › Smoking Behavior and Cessation
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Prenatal Substance Exposure Effects
Keywords
nicotine metabolism, pregnancy, nicotine metabolite ratio, cotinine, trans-3'-hydroxycotinine, nicotine replacement therapy, smoking cessation, postpartum period, pregnant smokers, salivary biomarkers
MeSH terms
Adult, Chromatography, Liquid, Cotinine, Female, United Kingdom, Humans, Longitudinal Studies, Nicotine, Pregnancy, Pregnancy Trimester, First, Pregnancy Trimester, Second, Pregnancy Trimester, Third, Saliva, Smoking, Postpartum Period, Tandem Mass Spectrometry, Multilevel Analysis, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review